[Tumor-associated macrophages: Function and differentiation].
Macrophages are important factors in the pathogenesis and prognosis of malignant tumors and represent a possible target for therapeutic intervention. Depending on the tumor entity and the prevalent polarization status, macrophages can be associated with a favorable or unfavorable clinical outcome. It is becoming clear, however, that the conventional definitions of M1 polarized tumor inhibitory and M2 polarized tumor promoting macrophages do not adequately reflect the heterogeneity and plasticity of macrophages. Macrophages can support tumor growth through direct interactions with the neoplastic cells, by promoting tissue remodeling and angiogenesis and by inhibiting local immune reactions. To achieve comparability of clinical studies, it will be necessary to reach a consensus nomenclature of macrophage polarization. Furthermore, methods for the quantitative characterization of macrophage populations in malignant tumors will have to be standardized. It is unlikely that single marker immunohistochemistry will be adequate in this context. In any case it is necessary to provide unequivocal information regarding the markers or marker combinations used.
Institut für Pathologie, Sana Klinikum Lichtenberg, Fanningerstr. 32, 10365, Berlin, Deutschland, g.niedobitek@sana-kl.de.
G
G
Niedobitek
M H
MH
Barros
J H
JH
Dreyer
F
F
Hauck
D
D
Al-Sheikhyaqoob
D002454:Cell Differentiation / Q000502:physiology*; D000066670:Cell Plasticity / Q000502:physiology; D016764:Cell Polarity / Q000502:physiology; D006801:Humans; D007108:Immune Tolerance / Q000502:physiology; D008264:Macrophages / Q000145:classification / Q000473:pathology* / Q000502:physiology*; D009369:Neoplasms / Q000098:blood supply / Q000276:immunology / Q000473:pathology* / Q000503:physiopathology*; D009389:Neovascularization, Pathologic / Q000473:pathology / Q000503:physiopathology